Suppr超能文献

肾脏疾病中β2-微球蛋白的肾脏处理:特别提及肝肾综合征

Renal handling of beta-2-microglobulin in renal disorders: with special reference to hepatorenal syndrome.

作者信息

Hall P W, Ricanati E S

出版信息

Nephron. 1981;27(2):62-6. doi: 10.1159/000182026.

Abstract

A study of serum beta 2-microglobulin and urinary beta 2-microglobulin in patients with liver and/or kidney disease was done to determine if such information is of diagnostic help. Serum concentrations and beta 2M/Cr clearance ratios are higher in patients with primary tubular disorders than in those with glomerular diseases, a finding unaltered by hepatic disease. These data suggest either an increased production or decreased tubular degradation of beta 2M, independent of the glomerular filtration rate (GFR), in primary tubular disorders. The marked increase in urinary beta 2-microglobulin that followed insertion of the peritoneal-jugular shunt is evidence that this procedure resulted in improvement of the GFR, in previously underperfused nephrons.

摘要

对患有肝脏和/或肾脏疾病的患者进行了血清β2-微球蛋白和尿β2-微球蛋白的研究,以确定此类信息是否具有诊断帮助。原发性肾小管疾病患者的血清浓度和β2M/Cr清除率高于肾小球疾病患者,这一发现不受肝脏疾病影响。这些数据表明,在原发性肾小管疾病中,β2M的产生增加或肾小管降解减少,与肾小球滤过率(GFR)无关。腹腔-颈静脉分流术后尿β2-微球蛋白显著增加,证明该手术改善了先前灌注不足的肾单位的GFR。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验